Takeda Pharmaceuticals faces yet another lawsuit involving allegations that it failed to warn of the bladder cancer risk associated with its type 2 diabetes medication Actos (generic: pioglitazone). What makes this complaint different is that it was filed by the insurance company Blue Cross, rather than on behalf of an individual plaintiff.
Free Confidential Lawsuit Evaluation: If you or a loved one developed bladder cancer after taking Actos, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Actos and our lawyers can help.
What’s the Problem?
June 24, 2014 – The new Actos Bladder Cancer Lawsuit was filed by Blue Cross in the Western District of Louisiana, and seeks damages for injuries to the company’s patients that were caused by the drug. The complaint states that as a result of the allegedly defective nature of Actos, patients who took the drug for one year or more have gone on to develop bladder cancer. Additionally, the lawsuit claims that Takeda “concealed and continue to conceal their knowledge that ACTOS can cause bladder cancer from Plaintiffs’ insured, other consumers, and the medical community.”
The complaint further states that a 2 year study of Actos on laboratory animals found drug-induced tumors in male rats. Another human study called Prospective Pioglitazaone Clinical Trial in Macrovascular Events (PROactive) identified an increased risk of bladder cancer in Actos users compared to patients who took other types of diabetes drugs, but this information was reportedly not included in a publicized account of the trial.
FDA Investigates Actos Bladder Cancer Link
In 2011, the U.S. Food & Drug Administration (FDA) announced that it had launched an ongoing investigation to examine the link between Actos and bladder cancer. FDA warned that “use of the diabetes medication ACTOS (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” The agency determined that taking Actos for more than a year was linked to approximately 27.5 extra cases of bladder cancer per 100,000 person-years compared to patients who took other types of diabetes drugs.
Blue Cross alleges that Takeda knew or should have known about the risks associated with Actos, but that the company marketed the product as safe and effective. The insurer further claims that there are a number of safer diabetes medications available on the market, but because of Takeda’s alleged actions, the public and medical communities could not have known about the risks.
“The information Defendants disseminated to physicians concerning ACTOS drug products was, in fact, inaccurate, misleading, and otherwise inadequate,” Blue Cross alleges.
Do I have an Actos Bladder Cancer Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Actos lawsuits. We are handling individual litigation nationwide and currently accepting new bladder cancer cases in all 50 states.
Free Confidential Case Evaluation: If you or a loved one was diagnosed with bladder cancer after taking Actos, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.